This study identifies facilitators and barriers to patient care in osteogenesis imperfecta, highlighting insights from medical providers and caregivers.
Objectives Limited research has examined facilitators and barriers that affect patient care in osteogenesis imperfecta (OI). The present study seeks to identify (1) facilitators and (2) barriers to care as reported by medical providers and caregivers of individuals with OI, and (3) common themes between both stakeholder groups.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: